Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure. - Wang R; Chen Y; Han J; Ye H; Yang H; Li Q; He Y; Ma B; Zhang J; Ge Y; Wang Z; Sun B; et al. (Nature communications, 2024)